A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+10.52%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$413M
AUM Growth
+$413M
Cap. Flow
+$8.72M
Cap. Flow %
2.11%
Top 10 Hldgs %
93.04%
Holding
20
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

1
ACET icon
Adicet Bio
ACET
$8.72M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 98.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$4B
$99.2M 24.03% 4,168,718 – –
VERA icon
2
Vera Therapeutics
VERA
$1.38B
$78.5M 19.03% 2,960,231 – –
JSPR icon
3
Jasper Therapeutics
JSPR
$45.5M
$44.1M 10.69% 5,628,558 – –
EFTR
4
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$39.9M 9.67% 4,822,114 – –
ACET icon
5
Adicet Bio
ACET
$59.9M
$36.9M 8.94% 2,115,385 +500,000 +31% +$8.72M
PHAT icon
6
Phathom Pharmaceuticals
PHAT
$864M
$23.6M 5.72% 1,203,135 – –
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$19.1M 4.62% 876,656 – –
OKUR
8
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$17.7M 4.3% 2,073,957 – –
VRNA
9
Verona Pharma
VRNA
$9.16B
$16.3M 3.95% 2,457,499 – –
SIEN
10
DELISTED
Sientra, Inc.
SIEN
$8.6M 2.08% 2,349,827 – –
NCNA
11
NuCana
NCNA
$6.09M
$7.93M 1.92% 3,333,333 – –
PRTK
12
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4.65M 1.13% 1,041,131 – –
SLNO icon
13
Soleno Therapeutics
SLNO
$3.6B
$4.22M 1.02% 10,302,602 – –
XCUR icon
14
Exicure
XCUR
$35.4M
$1.4M 0.34% 6,977,000 – –
SYRE icon
15
Spyre Therapeutics
SYRE
$996M
$1.14M 0.28% 240,500 – –
MTEM
16
DELISTED
Molecular Templates, Inc.
MTEM
$780K 0.19% 200,000 – –
CBAY
17
DELISTED
Cymabay Therapeutics
CBAY
$442K 0.11% 131,036 – –
OBSV
18
DELISTED
ObsEva SA Ordinary Shares
OBSV
$174K 0.04% 87,999 – –
OCGN icon
19
Ocugen
OCGN
$319M
$32K 0.01% 7,111 – –